| CD68 | Cluster of differentiation 68 (pan-macrophage marker) |
| CD80 | Cluster of differentiation 80 (M1 macrophage marker) |
| CD163 | Cluster of differentiation 163 (M2 macrophage marker) |
| DAB | 3,3′-Diaminobenzidine |
| DOI | Depth of invasion |
| FFPE | Formalin-fixed, paraffin-embedded |
| HPF | High-power field |
| HRM | Histologic risk model (Brandwein–Gensler classification) |
| IFG | Infiltration/growth pattern (Bryne’s classification) |
| IHC | Immunohistochemistry |
| IQR | Interquartile range |
| LHR | Lymphocytic host response |
| M0 | Undifferentiated (non-polarized) macrophage |
| M1 | Classically activated macrophage |
| M2 | Alternatively activated macrophage |
| OL | Oral leukoplakia |
| OPMD | Oral potentially malignant disorder |
| OSCC | Oral squamous cell carcinoma |
| PD-L1 | Programmed death-ligand 1 |
| PNI | Perineural invasion |
| STAT1 | Signal transducer and activator of transcription 1 |
| TAM | Tumor-associated macrophage |
| Th1 | T helper type 1 |
| Th2 | T helper type 2 |
| TMA | Tissue microarray |
| TME | Tumor microenvironment |
| WHO | World Health Organization |
| WPOI | Worst pattern of invasion |